Samsung Biologics Co. said it plans to carve its business into a contract drug manufacturer and a holding firm which will manage its subsidiaries through a spin-off.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...